Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion type Assertion NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_head.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion description "[The proportion of platelets expressing the activation-dependent antigens CD62p and TSP was higher in patients with ET (CD62p: 14.7+/-15.0%; TSP: 12.4+/-9.9%) as compared with healthy control subjects (CD62p: 3.0+/-4.0%; TSP: 3.2+/-3.2%; p< 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_provenance.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion evidence source_evidence_literature NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_provenance.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion SIO_000772 10588461 NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_provenance.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion wasDerivedFrom befree-20140225 NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_provenance.
- NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_assertion wasGeneratedBy ECO_0000203 NP480443.RAsAx_Q81WbVuAHtiP7ACnQdoUGzrcID0VgsGWG8-g_aw130_provenance.